Long-term efficacy, safety, and inhibition of joint destruction by adalimumab in psoriatic arthritis: Results from ADEPT

被引：0
|
作者：
Mease, Philip J.
Gladman, Dafna
Ritchlin, Christopher
Sasso, Eric
机构：
[1] Swedish Med Ctr, Seattle, WA USA
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ Rochester, Sch Med & Dent, Rochester, NY 14627 USA
[4] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2007年 / 127卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
104
引用
收藏
页码：1820 / 1820
页数：1
相关论文
共 50 条
  • [1] Clinical efficacy, safety and inhibition of joint destruction of adalimumab in the treatment of moderate to severe psoriatic arthritis: 48-week results of the ADEPT trial
    Mease, P
    Gladman, D
    Ritchlin, C
    Weinberg, M
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB214 - AB214
  • [2] Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)
    Mease, P. J.
    Ory, P.
    Sharp, J. T.
    Ritchlin, C. T.
    Van den Bosch, F.
    Wellborne, F.
    Birbara, C.
    Thomson, G. T. D.
    Perdok, R. J.
    Medich, J.
    Wong, R. L.
    Gladman, D. D.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (05) : 702 - 709
  • [3] Clinical efficacy and safety of adalimumab for psoriatic arthritis: 48-week results of ADEPT
    Mease, PJ
    Gladman, DD
    Ritchlin, CT
    Ruderman, EM
    Choy, EHS
    Steinfeld, SD
    Perdok, R
    Sasso, EH
    Weinberg, MA
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S215 - S215
  • [4] 24-Week efficacy and safety results from the adalimumab effectiveness in psoriatic arthritis trial (ADEPT)
    Mease, PJ
    Choy, EHS
    Gladman, DD
    Ritchlin, CT
    Ruderman, EM
    Steinfeld, SD
    Weinberg, MA
    RHEUMATOLOGY, 2005, 44 : I3 - I3
  • [5] Long-term efficacy of adalimumab for the treatment of psoriasis and psoriatic arthritis
    Papoutsaki, Marina
    Chimenti, Maria Sole
    Talamonti, Marina
    Chimenti, Sergio
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB175 - AB175
  • [6] Adalimumab treatment effects on radiographic progression of joint disease in patients with psoriatic arthritis: Results from ADEPT
    Mease, PJ
    Sharp, JT
    Ory, P
    Gladman, DD
    Ritchlin, CT
    Choy, EH
    Weinberg, MA
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 320 - 320
  • [7] Efficacy of adalimumab by disease duration in psoriatic arthritis: Subanalysis of ADEPT
    Choy, Ernest
    Gladman, Dafna
    Sasso, Eric
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB186 - AB186
  • [8] Inhibition of joint destruction in PsA with adalimumab: 48-week results of ADEPT.
    Mease, P
    Sharp, J
    Ory, P
    Gladman, D
    Ritchlin, C
    Choy, E
    Perdok, R
    Weinberg, M
    Sasso, E
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S631 - S631
  • [9] Efficacy and safety of adalimumab in psoriasis and psoriatic arthritis: ongoing results
    Papoutsaki, M
    Bianchi, L
    Chimenti, MS
    Di Stefani, A
    Diluvio, L
    Chimenti, S
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (01)
  • [10] Long-term efficacy and safety of secukinumab in patients with psoriatic arthritis
    Mahmood, Aysal
    Ali, Abraish
    Haider, Hoorain
    Zulfiqar, Beenish
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 118 : 152 - 154
12345